Iowa Medicaid Drug Utilization Review Commission

Annual Call for New Commission Members:
The Omnibus Budget Reconciliation Act (OBRA) of 1990 require(s) state Medicaid programs to have a drug utilization review (DUR) program consisting of prospective DUR, retrospective DUR, and an educational program.  The membership of the DUR Board shall include health care professionals who have recognized knowledge and expertise in one or more of the following:  1) The clinically appropriate prescribing of covered outpatient drugs; 2) The clinically appropriate dispensing and monitoring of covered outpatient drugs; 3) Drug use review, evaluation, and intervention; 4) Medical quality assurance.  The goal of the DUR program is to ensure appropriate medication therapy, while permitting appropriate professional judgment to individualize medication therapy.  

In Iowa, the DUR Board is referred to as the Iowa Medicaid DUR Commission.  The Iowa DUR Commission is comprised of four Iowa Licensed physicians and four Iowa Licensed pharmacists who serve up to two, four-year terms, as well as a representative from the Department of Human Services.  The Commission meets on the first Wednesday six months of the year (August, October, December, February, April, June) in Des Moines.  Meetings are scheduled from 9:30 a.m. to 1:30 p.m.  The Iowa DUR Commission is a recommending body to the Department of Human Services (DHS) on drug therapy including proDUR, drug prior authorization, coverage of medications and administrative and billing procedures.

The DUR Commission is currently seeking a Physician in Family Practice or Internal Medicine who serves Medicaid members to join the committee.  Any Physician interested in serving in this capacity should send a resume or curriculum vitae, as well as a letter indicating their interest to Pamela Smith at the address shown below.  Candidates that would like more information about the Commission or who would like to speak to a present Commissioner are encouraged to call.

The deadline for applications is April 30, 2013
Term begins July 1, 2013

Pamela Smith, R.Ph.
DUR Project Coordinator
Iowa Medicaid Drug Utilization Review Commission
100 Army Post Road
Des Moines, IA 50315
(515) 974-3131
info@iadur.org

 


New Public Comment Policy
Data that is to be referenced during the Public Comment period(s) should be limited to published, peer reviewed literature only. “Data on file” and “articles submitted for review” are not considered published, peer reviewed literature and should not be referenced during public testimony.

All referenced data that is to be presented should be submitted to the DUR professional staff electronically to info@iadur.org AT LEAST ONE WEEK PRIOR TO THE MEETING DATE for consideration and distribution to the Commission members. The deadline is 4:30 p.m. CT Wednesday, before the scheduled meeting date.  Anything submitted to the DUR professional staff after this deadline will be distributed to the Commission members for the next scheduled DUR meeting.

Recent Site Updates

New meeting information has been added.



A new DUR Digest has been added.

 


DUR Commission Members

  • Mark Graber, M.D., FACEP, Chairperson
  • Laurie Pestel, Pharm.D., Vice Chairperson
  • Larry Ambroson, R.Ph.
  • Gregory Barclay, M.D.
  • Brett Faine, Pharm.D.
  • Kellen Ludvigson, Pharm.D.
  • Susan Parker, Pharm.D.
  • Jason Wilbur, M.D.

More information

Professional Staff

  • Pam Smith, R.Ph. - DUR Project Coordinator